|
H9 [derivative of HuT 78] |
|
RC Gallo, M Popovic |
| Biosafety Level: |
1 |
|
frozen |
| Medium & Serum: |
See Propagation |
|
suspension |
|
Homo sapiens (human) |
|
lymphoblast
|
|
Disease: lymphoma
Cell Type: cutaneous T lymphocyte; |
|
interleukin-2 (interleukin 2, IL-2) |
|
In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. |
| |
|
transfection host (Roche FuGENE® Transfection Reagents) |
|
interleukin 2 (IL-2) |
|
human immunodeficiency virus 1 (HIV-1, also known as HTLV-III or LAV) |
|
Yes |
|
CD4; HLA A1, B62, C3, DR4, DQ3 |
|
Amelogenin: X,Y
CSF1PO: 11
D13S317: 8,12
D16S539: 11,12
D5S818: 11
D7S820: 8,11
THO1: 8,9
TPOX: 8,9
vWA: 14,15 |
|
This is a near triploid cell line (modal number = 69; range = 58 to 74). The frequency of higher ploidies is 2.5%. The line has an extremely complex karyotype with nearly 60% of the chromosomes in each cell being structurally altered marker chromosomes., Among the markers are t(3p4q), t(5q6q), t(5p6p), i(18q), i(18p); t(4q7p), and del(7)(q32). The first four of these are usually paired. Normal N4, N5, N6, N7, N10, N13, N18, N19, N20 an X are absent. |
|
AK-1, 0
|
|
